NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT00566696 2020-04-14Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesSt. Jude Children's Research HospitalPhase 2 Completed73 enrolled 16 charts
NCT00118352 2017-05-30Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed12 enrolled 10 charts
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled